These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23253254)

  • 81. New definition of borderline resectable colorectal liver metastasis based on prognostic outcomes.
    Chiba N; Iida S; Nakagawa M; Gunji T; Yokozuka K; Kobayashi T; Sano T; Shigoka M; Tabuchi S; Hidaka E; Kawachi S
    Langenbecks Arch Surg; 2024 Oct; 409(1):301. PubMed ID: 39377812
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy.
    Parikh AA; Ni S; Koyama T; Pawlik TM; Penson D
    J Gastrointest Surg; 2013 Nov; 17(11):1938-46. PubMed ID: 24018590
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases.
    Yedibela S; Elad L; Wein A; Dimmler A; Merkel S; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2005 Mar; 31(2):141-6. PubMed ID: 15698729
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
    Gawdi R; Valenzuela CD; Moaven O; Stauffer JA; Del Piccolo NR; Cheung T; Corvera CU; Wisneski AD; Cha C; Russell G; Zarandi N; Dourado J; Shen P
    J Surg Oncol; 2022 Aug; 126(2):339-347. PubMed ID: 35429409
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Chemotherapy and surgery: how can resection of colorectal cancer metastases to the liver be optimized?].
    Adam R; Ducreux M; Rougier P; Chaibi P; Mariette C
    J Chir (Paris); 2008 Apr; 145 Suppl 1():3S5-14. PubMed ID: 19024846
    [No Abstract]   [Full Text] [Related]  

  • 86. [Inversion of the sequence of surgery after neoadjuvant chemotherapy for synchronous liver metastases from colorectal cancer].
    Marín-Hargreaves G; Artigas V; González JA; Martínez C; Marcuello E; Trías-Folch M
    Cir Esp; 2007 Oct; 82(4):235-7. PubMed ID: 17942050
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
    Lee JM; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
    J Surg Oncol; 2023 Sep; 128(4):549-559. PubMed ID: 37288777
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Feasibility of "Watch-and-Wait" Management before Repeat Hepatectomy for Colorectal Liver Metastases.
    Kishi Y; Nara S; Esaki M; Shimada K
    Dig Surg; 2019; 36(3):233-240. PubMed ID: 29597209
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Optimal timing of systemic therapy in resectable colorectal liver metastases.
    Ihemelandu C; Levine EA; Aklilu M; Yacoub G; Howerton R; Bolemon B; Graham M; Russell G; Shen P
    Am Surg; 2013 Apr; 79(4):414-21. PubMed ID: 23574853
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis.
    Strowitzki MJ; Schmidt T; Keppler U; Ritter AS; Mahmoud S; Klose J; Mihaljevic AL; Schneider M; Büchler MW; Ulrich AB
    J Surg Oncol; 2017 Aug; 116(2):149-158. PubMed ID: 28409832
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Is preoperative systemic chemotherapy recommended for resectable colorectal liver metastases? Oncosurgical aspects].
    Dede K; Póti Z; Bursics A
    Orv Hetil; 2018 May; 159(21):823-830. PubMed ID: 29779391
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver.
    Baidoun F; Merjaneh Z; Nanah R; Saad AM; Abdel-Rahman O
    J Comp Eff Res; 2022 Sep; 11(13):935-951. PubMed ID: 35787069
    [No Abstract]   [Full Text] [Related]  

  • 93. Curative strategies for liver metastases from colorectal cancer: a review.
    Zdenkowski N; Chen S; van der Westhuizen A; Ackland S
    Oncologist; 2012; 17(2):201-11. PubMed ID: 22234631
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Multi-modality treatment of colorectal liver metastases.
    Cai GX; Cai SJ
    World J Gastroenterol; 2012 Jan; 18(1):16-24. PubMed ID: 22228966
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Managing colorectal cancer liver metastases.
    Wagman LD; Byun TE
    Oncology (Williston Park); 2009 Nov; 23(12):1063-71. PubMed ID: 20017288
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring.
    Di Martino M; Primavesi F; Syn N; Dorcaratto D; de la Hoz Rodríguez Á; Dupré A; Piardi T; Rhaiem R; Blanco Fernández G; de Armas Conde N; Rodríguez Sanjuán JC; Fernández Santiago R; Fernández-Moreno MC; Ferret G; López Ben S; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E
    Ann Surg Oncol; 2022 Oct; 29(11):6829-6842. PubMed ID: 35849284
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [China Guideline for Diagnosis and Comprehensive Treatment of Colorectal Liver Metastases (Version 2018)].
    Xu J; Ren L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):601-626. PubMed ID: 29968235
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Treatment of colorectal liver metastases.
    Ismaili N
    World J Surg Oncol; 2011 Nov; 9():154. PubMed ID: 22115124
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario?
    Sandhu L; Fox A; Nhan C; Barnett H; McLeod RS; Gallinger S; Moulton CA
    HPB (Oxford); 2012 Jun; 14(6):409-13. PubMed ID: 22568418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.